Inside Trump’s pressure campaign on federal scientists over a covid-19 treatment

Washington Post logo

President Trump’s accusatory tweet barreled in at 7:49 a.m. a week ago Saturday: The “deep state” at the Food and Drug Administration was trying to sandbag his election prospects by slowing progress on coronavirus treatments and vaccines until after Nov. 3.

Shocked and upset, FDA Commissioner Stephen Hahn, who was tagged in the tweet, immediately began calling his contacts at the White House to find out why the president was angry. During his conversations, he mentioned the FDA was on the verge of granting emergency authorization to convalescent plasma as a treatment for covid-19. The agency planned to issue a news release.

The White House would upend those plans, turning a preliminary finding of modest efficacy into something much bigger — a presidential announcement of a “major therapeutic breakthrough on the China Virus,” as White House press secretary Kayleigh McEnany previewed in a tweet late that Saturday night. Continue reading.

Secret Service copes with coronavirus cases in aftermath of Trump appearances

Washington Post logo

When President Trump gave a speech to a group of sheriffs in Tampa late last month, his decision to travel forced a large contingent of Secret Service agents to head to a state that was then battling one of the worst coronavirus surges in the nation.

Even before Air Force One touched down on July 31, the fallout was apparent: Five Secret Service agents already on the ground had to be replaced after one tested positive for the coronavirus and the others working in proximity were presumed to be infected, according to people familiar with the situation.

The previously unreported episode is one of a series of examples of how Trump’s insistence on traveling and holding campaign-style events amid the pandemic has heightened the risks for the people who safeguard his life, intensifying the strain on the Secret Service. Continue reading.

Two P.R. Experts at F.D.A. Have Been Ousted After Blood Plasma Fiasco

New York Times logo

The agency’s chief spokeswoman, Emily Miller, was removed from her position just 11 days into the job. And the contract was terminated of a consultant who had advised the F.D.A. chief to correct misleading claims about plasma’s benefits.

The head of the Food and Drug Administration ousted its top spokeswoman from her position on Friday in an urgent bid to restore the tarnished credibility of the agency after he made erroneous claims that overstated the benefits of plasma treatments for Covid-19 at a news conference with President Trump.

The decision came just a day after the F.D.A.’s parent agency, the Department of Health and Human Services, terminated the contract of a public relations consultant who had advised the F.D.A. commissioner, Dr. Stephen M. Hahn, to correct his misleading claims that 35 out of 100 Covid-19 patients “would have been saved because of the administration of plasma.”

The removals come at a moment when the agency, which will be making critical decisions about whether to approve coronavirus vaccines and treatments, is struggling to salvage its reputation as a neutral scientific arbiter. Continue reading.

Health agencies’ credibility at risk after week of blunders

WASHINGTON — The credibility of two of the nation’s leading public health agencies was under fire this week after controversial decisions that outside experts said smacked of political pressure from President Donald Trump as he attempts to move past the devastating toll of the coronavirus ahead of the November election.

The head of the Food and Drug Administration grossly misstated, then corrected, claims about the lifesaving power of a plasma therapy for COVID-19 authorized by his agency. Then the Centers for Disease Control and Prevention quietly updated its guidelines to suggest fewer Americans need to get tested for coronavirus, sparking outrage from scientists.

Trump’s own factual misstatements about COVID-19 are well documented, but the back-to-back messaging blunders by public health officials could create new damage, eroding public trust in front-line agencies. That’s already raising concerns about whether the administration will be forthcoming with critical details about upcoming vaccines needed to defeat the pandemic. Continue reading.

Shifting CDC testing guidance sparks backlash

The Hill logo

Public health experts warn that the Trump administration’s change to testing guidance is a step backward in the COVID-19 response that could lead to more cases, outbreaks and deaths.

The Centers for Disease Control and Prevention (CDC) altered its guidance this week to say people who have been exposed to COVID-19 “don’t necessarily need a test” if they don’t have symptoms, threatening contact tracing efforts which seek to stop lines of transmission. 

The change alarmed public health officials and experts, who note that about 40 percent of people with COVID-19 are asymptomatic, meaning they will never show symptoms of the virus and won’t know they have it without testing, but can spread it to others who may become seriously ill or die.  Continue reading.